Here are the top health stories for the day:
Insurance company must reimburse compensation for negligence by doctors as per policy liability: Supreme Court
In a recent judgment, the Supreme Court bench has held that the Insurance Company covering the doctors, will have to reimburse the compensation awarded to the complainant for any negligence to the extent of its liability covered under the Insurance Policy, as applicable to the concerned doctor.
Such a direction has been given by the top court bench of Justice A.S. Bopanna and Justice Dipankar Datta while considering an appeal challenging the order by the National Consumer Disputes Redressal Commission (NCDRC) directing compensation to a complainant in a medical negligence case. The bench rejected the hospital's appeal and held that insurers must reimburse compensation to the Complainant to the extent of its liability under the policy.
For more details, check out the link given below:
CDSCO Drug Alert: 48 drug samples flagged not of standard quality
In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 48 medicine batches for failing to qualify random drug sample test for the month of March-2023.
These drugs samples include Telmisartan Tablets manufactured by Ridley Life Sciences, Domperidone Tablets manufactured by Karnataka Antibiotics & Pharmaceuticals, Pioglitazone Hydrochloride Tablets manufactured by Skymap Pharmaceutical, Domperidone Tablets manufactured by Rivpra Formulation, Gabapentin Tablets manufactured by Synokem Pharmaceuticals and Mascot Health Series, Rolled Bandage (Non Sterilized, Size 15cm x 4 mts manufactured by Disha Surgicals, Dactinomycin for Injection USP 0.5 mg by Celon Laboratories, Iron and Folic Acid Tablets I.P. manufactured by Nestor Pharmaceuticals and others.
For more details, check out the link given below:
CDSCO Drug Alert: 48 Drug Samples Flagged Not Of Standard Quality
NAMO Medical Education and Research Institute inaugurated by PM Modi in Silvassa
The Prime Minister, Shri Narendra Modi inaugurated NAMO Medical Education & Research Institute in Silvassa. The medical college will offer 177 MBBS seats including 27 seats for EWS category students.
He also laid the foundation stone and dedicated to the nation various development projects worth more than Rs 4850 crores at Silvassa, Dadra and Nagar Haveli.
For more details, check out the link given below:
Medical students from Ukraine upset with NMC's 2-year internship rule, stage protest
Upset with the National Medical Commission (NMC) rule that mandated a two-year internship programme for foreign medical graduates, Ukraine returned medical students on Monday staged a protest.
Referring to the fact that Indian medical students are required to undergo only one year of internship, the medical students from Ukraine protested at the Bhopal office of NMC.
The COVID-19 pandemic and then the war between Ukraine and Russia had put a question mark on the future of several Indian medical students, who are enrolled at foreign medical institutes in China and Ukraine.
For more details, check out the link given below:
Medical Students From Ukraine Upset With NMC's 2-Year Internship Rule, Stage Protest
NMC nod to 150 MBBS seats at GMC Nandyal
Bringing good news to the medical aspirants in Andhra Pradesh, the National Medical Commission (NMC) has given its nod for 150 MBBS seats at Government Medical College at Nandyal.
The apex medical education regulatory body NMC has permitted the State to commence the MBBS admission in 150 seats at the medical college from the academic year 2023-2024.
Medical Dialogues team had earlier reported that medical colleges at Eluru, Vizianagaram, Rajamahendravaram, Nandyal and Machilipatnam districts of the State will commence the MBBS admission process in 150 MBBS seats each.
For more details, check out the link given below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.